Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,856 | 3,067 | 3,051 | 3,266 | 2,238 |
| Cost of Goods | 1,418 | 908 | 1,016 | 755 | 1,359 |
| Gross Profit | 438 | 2,159 | 2,035 | 2,511 | 879 |
| Operating Expenses | 47,671 | 29,138 | 31,096 | 31,580 | 30,222 |
| Operating Income | -46,815 | -26,071 | -29,045 | -28,314 | -28,984 |
| Interest Expense | 2,076 | 2,072 | 2,091 | 2,141 | 2,170 |
| Other Income | 1,323 | 16 | -5,362 | 43 | 42 |
| Pre-tax Income | -47,568 | -28,127 | -36,498 | -30,412 | -31,112 |
| Net Income Continuous | -47,568 | -28,127 | -36,498 | -30,412 | -31,112 |
| Net Income | $-47,568 | $-28,127 | $-36,498 | $-30,412 | $-31,112 |
| EPS Basic Total Ops | -33.91 | -21.41 | -28.50 | -24.50 | -26.50 |
| EPS Basic Continuous Ops | -34.01 | -21.42 | -28.27 | -24.66 | -26.80 |
| EPS Diluted Total Ops | -33.91 | -21.41 | -28.50 | -24.50 | -26.50 |
| EPS Diluted Continuous Ops | -34.01 | -21.42 | -28.27 | -24.66 | -26.80 |
| EBITDA(a) | $-46,164 | $-25,377 | $-28,422 | $-27,788 | $-28,474 |